Illumina, Inc. (ILMN) Financial Statements
Industry: Laboratory Analytical Instruments
In fiscal 2025, Illumina reported revenue of $4.34B, down 0.7% from $4.37B the year before. Net income was $850.0M (a 19.6% net margin), or $5.45 per diluted share. Gross margin was 66.1% and operating margin was 18.6%. Operating activities generated $1.08B of cash, leaving $931.0M of free cash flow. At fiscal year end, Illumina held $6.64B in total assets against $3.92B in total liabilities.
Open the full interactive Illumina financials → Quarterly statements, key ratios, valuation history and price charts.
Illumina Key Stats
| Share Price | $271.18 |
|---|---|
| Market Cap | $41.49B |
| P/E Ratio | 49.8 |
| Revenue YoY Growth | -0.7% |
| 52-Week Range | $91.00 – $293.69 |
| Shares Outstanding | 151.0 million (basic, 2026 Q2) |
Illumina Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $3.24B | $4.53B | $4.58B | $4.50B | $4.37B | $4.34B |
| Cost of Goods Sold | — | $1.06B | $1.14B | $1.18B | $1.02B | $1.11B |
| Gross Profit | $2.20B | $3.15B | $2.97B | $2.74B | $2.86B | $2.87B |
| Operating Income | $580.0M | -$123.0M | -$4.18B | -$1.07B | -$833.0M | $807.0M |
| Pre-Tax Income | $856.0M | $884.0M | -$4.34B | -$1.12B | -$1.18B | $1.09B |
| Income Tax | $200.0M | $122.0M | $68.0M | $44.0M | $44.0M | $236.0M |
| Net Income | $656.0M | $762.0M | -$4.40B | -$1.16B | -$1.22B | $850.0M |
| Diluted EPS | $4.45 | $5.04 | -$28.00 | -$7.34 | -$7.69 | $5.45 |
Illumina Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $1.08B | $1.16B | $1.09B | $1.16B |
| Net Income | $150.0M | $334.0M | $134.0M | $207.0M |
| Diluted EPS | $0.98 | $2.14 | $0.87 | $1.35 |
Illumina Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Current Assets | $4.48B | $2.71B | $3.56B | $2.61B | $2.75B | $3.29B |
| Total Assets | $7.58B | $15.22B | $12.25B | $10.11B | $6.30B | $6.64B |
| Current Liabilities | $1.24B | $1.09B | $2.77B | $1.57B | $1.55B | $1.58B |
| Total Long-Term Debt | $1.18B | $1.70B | $1.49B | $1.49B | $1.99B | $1.99B |
| Total Liabilities | $2.89B | $4.48B | $5.65B | $4.37B | $3.93B | $3.92B |
| Shareholders' Equity | $4.69B | $10.74B | $6.60B | $5.75B | $2.37B | $2.72B |
Illumina Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $1.08B | $545.0M | $392.0M | $478.0M | $837.0M | $1.08B |
| Cash From Investing | -$554.0M | -$1.07B | -$591.0M | -$231.0M | -$178.0M | -$55.0M |
| Cash From Financing | -$766.0M | -$51.0M | $1.00B | -$1.21B | -$570.0M | -$744.0M |
| Free Cash Flow | $891.0M | $337.0M | $106.0M | $283.0M | $709.0M | $931.0M |
Figures from Illumina's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Illumina financials page for every line item.
Illumina Company Profile
| Ticker | ILMN |
|---|---|
| Exchange | Nasdaq |
| Industry | Laboratory Analytical Instruments |
| Headquarters | San Diego, California |
| Incorporated in | Delaware |
| Fiscal Year End | January 3 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001110803 |
Frequently Asked Questions
What was Illumina's revenue in fiscal 2025?
Illumina (ILMN) reported revenue of $4.34B for fiscal 2025.
What is Illumina's annual revenue history?
Illumina's annual revenue by fiscal year: 2020: $3.24B; 2021: $4.53B; 2022: $4.58B; 2023: $4.50B; 2024: $4.37B; 2025: $4.34B.
What was Illumina's net income in fiscal 2025?
Illumina reported net income of $850.0M for fiscal 2025.
What was Illumina's earnings per share (EPS) in fiscal 2025?
Illumina's diluted EPS was $5.45 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Illumina generate in fiscal 2025?
Illumina generated $931.0M of free cash flow in fiscal 2025.
What was Illumina's revenue last quarter?
In its most recent reported quarter (2026 Q2), Illumina reported revenue of $1.16B.
How much debt does Illumina have?
Illumina reported $1.99B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Illumina are outstanding?
Illumina reported a weighted average of 151.0 million basic shares outstanding in 2026 Q2.
What is Illumina's market cap?
Based on its latest closing price, Illumina (ILMN) has a market capitalization of about $41.49B.
When does Illumina's fiscal year end?
Illumina's fiscal year end, as registered with the SEC, is January 3.
Where is Illumina headquartered?
Illumina lists its business address in San Diego, California in its SEC filings.